| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 耳形羊耳兰碱; Auriculine | CFN00301 | 22595-00-2 | C31H45NO8 = 559.70 | 5mg | QQ客服：1413575084 |
| Phalaenopsine T; Phalaenopsine T | CFN00302 | 23412-97-7 | C20H27NO5 = 361.44 | 5mg | QQ客服：2056216494 |
| Phalaenopsine La; Phalaenopsine La | CFN00303 | 23412-99-9 | C20H27NO5 = 361.44 | 5mg | QQ客服：2159513211 |
| 1,4-二氢-1,2-二甲基-4-氧代-3-喹啉羧酸; 1,4-Dihydro-1,2-dimethyl-4-oxo-3-quinolinecarboxylic acid | CFN97215 | 73281-83-1 | C12H11NO3 = 217.2 | 5mg | QQ客服：3257982914 |
| Phalaenopsine Is; Phalaenopsine Is | CFN00304 | 41451-64-3 | C20H27NO5 = 361.44 | 5mg | QQ客服：3257982914 |
| Procerine; Procerine | CFN00305 | 68622-81-1 | C13H21NO5 = 271.31 | 5mg | QQ客服：2056216494 |
| Punctanecine; Punctanecine | CFN00306 | 145204-91-7 | C20H33NO6 = 383.48 | 5mg | QQ客服：1457312923 |
| Chysin A; Chysin A | CFN00308 | 22269-11-0 | C9H15NO2 = 169.22 | 5mg | QQ客服：1457312923 |
| 瓶千里光碱; Sarracine | CFN00309 | 2492-09-3 | C18H27NO5 = 337.41 | 5mg | QQ客服：3257982914 |
| 瓶千里光碱N-氧化物; Sarracine N-oxide | CFN00310 | 19038-27-8 | C18H27NO6 = 353.41 | 5mg | QQ客服：2159513211 |
| Racemodine; Racemodine | CFN00311 | 147554-28-7 | C23H35NO7 = 437.53 | 5mg | QQ客服：2056216494 |
| Neosarranicine; Neosarranicine | CFN00312 | 136173-27-8 | C18H27NO5 = 337.41 | 5mg | QQ客服：1413575084 |
| Sarranicine; Sarranicine | CFN00313 | 136173-25-6 | C18H27NO5 = 337.41 | 5mg | QQ客服：215959384 |
| 新瓶草千里光碱; Neosarracine | CFN00314 | 136173-26-7 | C18H27NO5 = 337.41 | 5mg | QQ客服：2159513211 |
| Scorpioidine; Scorpioidine | CFN00315 | 80405-18-1 | C20H31NO6 = 381.47 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)